Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-27

Clinical Trial Update: A Basket Study of Vosoritide in Children With Turner Syndrome, Short Stature Homeobox-Containing Gene Deficiency, and Noonan Syndrome With Inadequate Growth During or After Human Growth Hormone Treatment [Phase 2]

View source ↗

Summary

Recruitment is ongoing for a Phase 2 basket study evaluating Vosoritide in children with SHOX deficiency, Turner syndrome, or Noonan syndrome who have inadequat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vosoritide (vosoritide)

Snippet

Sponsor: BioMarin Pharmaceutical | Conditions: Short Stature Homeobox- Containing Gene SHOX Deficiency, Noonan Syndrome | Phase 2 | Status: RECRUITING